Ciphergen this week said that Daniel Caserza, the company's interim chief financial officer, will resign effective from the company on June 2. Gail Page, president and CEO, will take his place until Ciphergen hires a replacement, the company said.

Ciphergen also said it has retained Financial Leadership Group to help it prepare its financial statements until it hires a permanent CFO.

Casera took over from Matthew Hogan, who abruptly resigned in March. Caserza joined Ciphergen in 1999. He became a vice president in April 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.